ABSTRACT
Venous thromboembolism (VTE), which encompasses both deep vein thrombosis (DVT) and pulmonary embolism (PE), is an important cause of maternal morbidity and mortality. VTE is a significant cause of maternal death in resource-rich countries, with a case fatality rate for PE in pregnancy at 2.4% [1]. Alongside the short-term morbidity and mortality associated with VTE, long-term consequences such as post-thrombotic syndrome (PTS), which can vary from edema and skin changes to recurrent thrombosis and ulceration, should not be disregarded [2].
